UK foreign office to review pay-off to Epstein-linked US envoy

Weather - Sydney 9°C

UK foreign office to review pay-off to Epstein-linked US envoy

ECONOMY 08.02.2026

UK foreign office to review pay-off to Epstein-linked US envoy / Photo: © AFP

The UK foreign ministry said on Sunday it was reviewing an exit payment to former US envoy Peter Mandelson, who was sacked over links to convicted US sex offender Jeffrey Epstein.

Change text size:

Mandelson received an estimated pay-out of between £38,750 and £55,000 ($52,000 and $74,000) after only seven months in the job as British ambassador to the United States, according to a report in the Sunday Times.

Documents released on January 30 by the US Justice Department appear to show that Mandelson allegedly leaked confidential UK government information to the late Epstein when he was a British minister, including during the 2008 financial crisis.

The revelation has placed intense pressure on Labour Prime Minister Keir Starmer and triggered a police investigation into party insider Mandelson, 72, for alleged misconduct in a public office.

The Foreign Office said in a statement it had launched a review into Mandelson's severance payment "in light of further information that has now been revealed and the ongoing police investigation".

Cabinet minister Pat McFadden insisted Starmer should remain in office despite his "terrible mistake" in appointing Mandelson.

The close Starmer ally told broadcasters the party should stick with the prime minister.

"He (Starmer) should be realistic and accept that this has been a terrible story, that this appointment was a terrible mistake," McFadden, the Work and Pensions Secretary, told BBC television.

He said the real blame lay "squarely with Peter Mandelson", who put himself forward for the job despite knowing the extent of his relationship with Epstein.

- Pivotal figure -

Starmer's deputy, David Lammy, became the first cabinet minister to appear to distance himself from the premier, according to a report in the Sunday Telegraph.

The minister had not been in favour of appointing Mandelson, a pivotal figure in British politics for decades, due to his known links to Epstein, the report quoted friends of Lammy as saying.

Starmer's Labour Party took power just over 18 months ago in a landslide election victory.

But it has been trailing Nigel Farage's anti-immigrant Reform UK as the government has come under fire over immigration, economic growth and the cost of living crisis.

Reform UK has led by double-digit figures in the polls for the past year.

Mandelson, also a former European Union trade commissioner, stood down from parliament's unelected upper chamber, the House of Lords, earlier this week.

Starmer fired him in September following an earlier release of Epstein documents.

The ex-envoy was one of numerous prominent figures again embarrassed by last week's latest revelations of ties to financier Epstein, who died in jail in 2019 while facing charges of alleged sex trafficking.

US officials ruled Epstein's death a suicide.

A spokesperson for law firm Mishcon de Reya, representing Mandelson, said the latter "regrets, and will regret until to his dying day, that he believed Epstein's lies about his criminality".

"Lord Mandelson did not discover the truth about Epstein until after his death in 2019. He is profoundly sorry that powerless and vulnerable women and girls were not given the protection they deserved," the law firm said.

A.Robinson--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size:

The National Times - UK foreign office to review pay-off to Epstein-linked US envoy